Targeted binding of PLA microparticles with lipid-PEG-tethered ligands

被引:75
作者
Duncanson, Wynter J.
Figa, Michael A.
Hallock, Kevin
Zalipsky, Samuel
Hamilton, James A.
Wong, Joyce Y.
机构
[1] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA
[2] Boston Univ, Med Ctr, Dept Physiol & Biophys, Boston, MA 02118 USA
[3] ALZA Corp, Mountain View, CA 94039 USA
关键词
drug delivery; microsphere; surface modification; poly(lactic acid); lipid;
D O I
10.1016/j.biomaterials.2007.05.044
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Solid core polymeric particles are an attractive delivery vehicle as they can efficiently encapsulate drugs of different physical and chemical characteristics. However, the effective targeting of such particles for therapeutic purposes has been somewhat elusive. Here, we report novel polymeric particles comprised of poly(lactic acid) (PLA) with incorporated poly(ethylene glycol)-lipids (PEG-lipids). Particles are characterized for morphology, surface charge, and composition with field-emission scanning electron microscopy (FESEM), zeta potential measurements, and proton nuclear magnetic resonance (H-1 NNIR) spectroscopy, respectively. The surface densities of PEG lipids determined by 1H NMR and particle size distributions are consistent with scaling theory for adsorption of chains onto a surface. We observe significant binding of liganded PEG-lipid tethers when the molecular weight is greater than the unliganded PEG-lipids for significant binding events. Importantly, the binding is not completely lost when the unliganded PEG molecular weight is greater than the liganded PEG-lipid tether. We observe a similar trend for the lower affinity ligand (thioctic acid), but the degree of binding is significantly lower than the high affinity ligand (biotin). This novel technique used to fabricate these liganded particles combined with the lipid bilayer binding studies provides a platform for systematic optimization of particle binding. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4991 / 4999
页数:9
相关论文
共 51 条
[1]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[2]   STEALTH ME.PEG-PLA NANOPARTICLES AVOID UPTAKE BY THE MONONUCLEAR PHAGOCYTES SYSTEM [J].
BAZILE, D ;
PRUDHOMME, C ;
BASSOULLET, MT ;
MARLARD, M ;
SPENLEHAUER, G ;
VEILLARD, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) :493-498
[3]   In vitro degradation of nanospheres from poly(D,L-lactides) of different molecular weights and polydispersities [J].
Belbella, A ;
Vauthier, C ;
Fessi, H ;
Devissaguet, JP ;
Puisieux, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 129 (1-2) :95-102
[4]   Patterning adjacent supported lipid bilayers of desired composition to investigate receptor-ligand binding under shear flow [J].
Burridge, KA ;
Figa, MA ;
Wong, JY .
LANGMUIR, 2004, 20 (23) :10252-10259
[5]  
Chen JH, 2005, IEEE CIRCUITS DEVICE, V21, P12
[6]   Design and characterisation of new nanoparticulate polymer blends for drug delivery [J].
Csaba, N ;
González, L ;
Sánchez, A ;
Alonso, MJ .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2004, 15 (09) :1137-1151
[7]   Sialyl Lewis x liposomes as a multivalent ligand and inhibitor of E-selectin mediated cellular adhesion [J].
DeFrees, SA ;
Phillips, L ;
Guo, L ;
Zalipsky, S .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (26) :6101-6104
[8]   Target specific optimization of cationic lipid-based systems for pulmonary gene therapy [J].
Deshpande, D ;
Blezinger, P ;
Pillai, R ;
Duguid, J ;
Freimark, B ;
Rolland, A .
PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1340-1347
[9]   Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs [J].
Dong, YC ;
Feng, SS .
BIOMATERIALS, 2004, 25 (14) :2843-2849
[10]   Development of a novel method for synthesis of a polymeric ultrasound contrast agent [J].
El-Sherif, DM ;
Wheatley, MA .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2003, 66A (02) :347-355